TSHA Taysha Gene Therapies, Inc.
$4.10
Taysha Gene Therapies, Inc. (TSHA) Earnings News
Earnings press releases, previews and reviews for Taysha Gene Therapies, Inc. (TSHA), newest first. Our most recent is review: Taysha Beats on a Narrower-Than-Expected Loss as PPQ Completion De-Risks TSHA-102, but the Investment Case Now Rests on One Binary 1H 2027 Event.
Thursday
November 12, 2026
10:56 AM ET
Taysha Beats on a Narrower-Than-Expected Loss as PPQ Completion De-Risks TSHA-102, but the Investment Case Now Rests on One Binary 1H 2027 Event
Earnings Whispers · Review
Thursday
November 12, 2026
7:30 AM ET
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Friday
November 6, 2026
5:38 PM ET
Taysha Heads Into Q3 With Pivotal Dosing Done, a Fat Cash Cushion and a Stock Down a Third
Earnings Whispers · Preview
Thursday
November 5, 2026
8:00 AM ET
Taysha Gene Therapies to Release Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 12
Tuesday
August 11, 2026
4:00 PM ET
Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Tuesday
August 4, 2026
4:00 PM ET
Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11